1.
Molecular docking and dynamics analysis to reveal the therapeutic potential of Dostarlimab against novel immune targets in liver cancer. IJBB [Internet]. 2024 Oct. 11 [cited 2026 May 16];61(11):740-55. Available from: https://or.niscpr.res.in/index.php/IJBB/article/view/12051